The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2020

Filed:

Jan. 16, 2019
Applicant:

Turnstone Limited Partnership, Toronto, CA;

Inventors:

David F. Stojdl, Ottawa, CA;

John Cameron Bell, Ottawa, CA;

Brian Lichty, Brantford, CA;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C12N 15/86 (2006.01); A61K 39/12 (2006.01); A61K 35/766 (2015.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0005 (2013.01); A61K 35/766 (2013.01); A61K 39/0011 (2013.01); A61K 39/12 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/572 (2013.01); A61K 2039/585 (2013.01); C07K 2319/00 (2013.01); C07K 2319/50 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/16234 (2013.01); C12N 2710/20034 (2013.01); C12N 2740/15043 (2013.01); C12N 2760/20223 (2013.01); C12N 2760/20232 (2013.01); C12N 2760/20242 (2013.01); C12N 2760/20243 (2013.01);
Abstract

There is described a kit for use in inducing an immune response in a mammal, the kit includes: a first virus that expresses MAGEA3, Human Papilloma Virus E6/E7 fusion protein, human Six-Transmembrane Epithelial Antigen of the Prostate protein, or Cancer Testis Antigen 1, or a variant thereof as an antigenic protein and that is formulated to generate an immunity to the protein or variant thereof in the mammal. The kit also includes a Maraba MG1 virus encoding the same antigen, or a variant of the same antigen. The Maraba MG1 virus is formulated to induce the immune response in the mammal. The first virus is immunologically distinct from the Maraba MG1 virus.


Find Patent Forward Citations

Loading…